Skip to Main Content
ManagedCareEye.com
This website is supported by an independent medical education grant from Regeneron Pharmaceuticals, Inc.
  • Home
  • CE Activities
  • Faculty
  • Expert Updates
  • Outcomes
  • Resources

Spotlight on Diabetic Retinopathy & Diabetic Macular Edema

November 1, 2022

FEATURING: W. Lloyd Clark, MD, Jeffrey Dunn, PharmD, MBA, and Dana McCormick, RPh, FAMCP

← Spotlight on Age-Related Macular Degeneration   Facilitating Optimal Outcomes for the Management of Retinal Diseases:
Health Plan Best Practice Recommendations
Managed Care Pathway for Better Management of Diabetic Retinopathy (DR) and Diabetic Macular Edema (DME) →
  • About Impact Education, LLC
  • Contact Us (IMPACT)
  • Mailing List (IMPACT)
  • Privacy Policy

Jointly provided by

Medical Education Resources Impact Education, LLC

Supported by an independent medical education grant from Regeneron Pharmaceuticals, Inc.

NEW Publication

Assessing Variation in Payer Coverage of Anti-VEGF Therapies for Retinal Diseases

Read Now